We just heard news that the popular treatment of HCV/Hepatitis C
ribavirin and peginterferon alfa will be discontinued on February 1st
2016. These drugs were a commonly prescribed with Sovaldi (sofosbuvir
400mg).
Ribavirin's brand name Rebetol capsules
by Merck will no longer be available due to business reasons not health
or treatment issues with HCV/Hepatitis C as stated by the FDA Rebetol for
patients ≥3 years of age with compensated liver disease. It is supplied
as 200mg capsules in 56-, 70-, and 84-count bottles.
FDA
also stated PegIntron (peginterferon alfa-2b) for injection by Merck
will also be discontinued. Again reasons are business related not
safety or efficacy issues with peginterferon alfa-2b.
What will be the alternatives, maybe generic version from Canada or India.
We will keep you updated.
No comments:
Post a Comment